As shown in Figure 6B and in agreement with earlier analyses, the IED68 signature was enhanced in tumors that were infiltrated with CD8+ and NK cells, characterized by the expression of inhibitory molecules, and inversely correlated with leukemia burden (Figure 6C). Here, CD8A is linked to leukemia.